Rodriguez L, Zamora J, Han D, Moshiri J, Peinovich N, Martinez C
Viruses. 2025; 17(2).
PMID: 40006923
PMC: 11860839.
DOI: 10.3390/v17020168.
Yuan Z
Molecules. 2025; 30(4).
PMID: 40005257
PMC: 11858448.
DOI: 10.3390/molecules30040947.
Singh D, Kushwaha T, Kulandaisamy R, Kumar V, Baswal K, Tiwari S
Mol Ther Nucleic Acids. 2025; 36(1):102452.
PMID: 39944792
PMC: 11816038.
DOI: 10.1016/j.omtn.2025.102452.
Wu L, Liu Y, Shi W, Chang T, Liu P, Liu K
Proc Natl Acad Sci U S A. 2025; 122(6):e2420162122.
PMID: 39903107
PMC: 11831205.
DOI: 10.1073/pnas.2420162122.
Wang Y, Xia B, Gao Z
J Virol. 2025; 99(2):e0204924.
PMID: 39878471
PMC: 11852741.
DOI: 10.1128/jvi.02049-24.
Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 M.
Ren J, Zhang Z, Xia Y, Zhao D, Li D, Zhang S
Molecules. 2025; 30(2).
PMID: 39860219
PMC: 11767629.
DOI: 10.3390/molecules30020351.
Single-molecule assay reveals the impact of composition, RNA duplex, and inhibitors on the binding dynamics of SARS-CoV-2 polymerase complex.
Lovell T, Dewling H, Li C, Lee H, Gordon C, Kocincova D
bioRxiv. 2025; .
PMID: 39829757
PMC: 11741280.
DOI: 10.1101/2025.01.10.632212.
High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination.
Anglero-Rodriguez Y, Lempp F, Subramanian M, McIninch J, Schlegel M, Bohan D
Nucleic Acids Res. 2024; 53(1.
PMID: 39657790
PMC: 11724309.
DOI: 10.1093/nar/gkae1195.
Enhanced detection and molecular modeling of adaptive mutations in SARS-CoV-2 coding and non-coding regions using the c/µ test.
Paradis N, Wu C
Virus Evol. 2024; 10(1):veae089.
PMID: 39584063
PMC: 11584280.
DOI: 10.1093/ve/veae089.
Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor Activity.
Chen B, Sun M, Zhang C, Huang Q, Teng D, Hu L
J Med Chem. 2024; 67(23):21009-21029.
PMID: 39574384
PMC: 11647907.
DOI: 10.1021/acs.jmedchem.4c01605.
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors.
Wang X, Xiong L, Zhu Y, Liu S, Zhao W, Wu X
J Am Chem Soc. 2024; 146(49):33983-33996.
PMID: 39574309
PMC: 11673110.
DOI: 10.1021/jacs.4c12992.
Viral N protein hijacks deaminase-containing RNA granules to enhance SARS-CoV-2 mutagenesis.
Li Z, Luo L, Ju X, Huang S, Lei L, Yu Y
EMBO J. 2024; 43(24):6444-6468.
PMID: 39567830
PMC: 11649915.
DOI: 10.1038/s44318-024-00314-y.
Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments.
Novitsky V, Beckwith C, Carpenter-Azevedo K, Shin J, Hague J, Sam S
Viruses. 2024; 16(10).
PMID: 39459846
PMC: 11512361.
DOI: 10.3390/v16101511.
Binding Mechanism of the Active Form of Molnupiravir to RdRp of SARS-CoV-2 and Designing Potential Analogues: Insights from Molecular Dynamics Simulations.
Carbone J, Paradis N, Brunt D, Wu C
ACS Omega. 2024; 9(40):41583-41598.
PMID: 39398139
PMC: 11465654.
DOI: 10.1021/acsomega.4c05469.
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections.
Nooruzzaman M, Johnson K, Rani R, Finkelsztein E, Caserta L, Kodiyanplakkal R
Nat Commun. 2024; 15(1):7999.
PMID: 39294134
PMC: 11411086.
DOI: 10.1038/s41467-024-51924-3.
Computational investigation of novel synthetic analogs of C-1'β substituted remdesivir against RNA-dependent RNA-polymerase of SARS-CoV-2.
Cardoza S, Singh A, Sur S, Singh M, Dubey K, Samanta S
Heliyon. 2024; 10(17):e36786.
PMID: 39286185
PMC: 11402944.
DOI: 10.1016/j.heliyon.2024.e36786.
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.
Wang S, Li W, Wang Z, Yang W, Li E, Xia X
Signal Transduct Target Ther. 2024; 9(1):223.
PMID: 39256346
PMC: 11412324.
DOI: 10.1038/s41392-024-01917-x.
Inilico assessment of hesperidin on SARS-CoV-2 main protease and RNA polymerase: Molecular docking and dynamics simulation approach.
Molaakbari E, Aallae M, Golestanifar F, Garakani-Nejad Z, Khosravi A, Rezapour M
Biochem Biophys Rep. 2024; 39:101804.
PMID: 39193225
PMC: 11347860.
DOI: 10.1016/j.bbrep.2024.101804.
Suppressive Potential of L. Extract against Triple-Negative and Luminal A Breast Cancer.
Eghbalpour K, Eghbalpour N, Khademi S, Arzi L
Int J Mol Cell Med. 2024; 13(2):198-209.
PMID: 39184822
PMC: 11344568.
DOI: 10.22088/IJMCM.BUMS.13.2.198.
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (M).
Yang Y, Luo Y, Zhang C, Xiang Y, Bai X, Zhang D
ACS Omega. 2024; 9(32):34196-34219.
PMID: 39157135
PMC: 11325518.
DOI: 10.1021/acsomega.4c03023.